IDXX
Income statement / Annual
Last year (2025), Idexx Laboratories, Inc.'s total revenue was $4.30 B,
an increase of 10.42% from the previous year.
In 2025, Idexx Laboratories, Inc.'s net income was $1.06 B.
See Idexx Laboratories, Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2025
|
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
| Period Ended |
12/31/2025 |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
| Operating Revenue |
$4.30 B |
$3.90 B |
$3.66 B |
$3.37 B |
$3.22 B |
$2.71 B |
$2.41 B |
$2.21 B |
$1.97 B |
$1.78 B |
| Cost of Revenue |
$1.64 B
|
$1.52 B
|
$1.47 B
|
$1.36 B
|
$1.33 B
|
$1.14 B
|
$1.04 B
|
$971.70 M
|
$871.68 M
|
$799.99 M
|
| Gross Profit |
$2.66 B
|
$2.38 B
|
$2.19 B
|
$2.00 B
|
$1.89 B
|
$1.57 B
|
$1.37 B
|
$1.24 B
|
$1.10 B
|
$975.44 M
|
| Gross Profit Ratio |
0.62
|
0.61
|
0.6
|
0.6
|
0.59
|
0.58
|
0.57
|
0.56
|
0.56
|
0.55
|
| Research and Development Expenses |
$251.21 M
|
$219.79 M
|
$190.95 M
|
$254.82 M
|
$161.01 M
|
$141.25 M
|
$133.19 M
|
$117.86 M
|
$109.18 M
|
$101.12 M
|
| General & Administrative Expenses |
$404.79 M
|
$442.29 M
|
$335.83 M
|
$326.25 M
|
$309.66 M
|
$300.83 M
|
$261.32 M
|
$244.94 M
|
$220.88 M
|
$207.02 M
|
| Selling & Marketing Expenses |
$643.55 M
|
$588.51 M
|
$566.07 M
|
$524.51 M
|
$486.74 M
|
$434.44 M
|
$418.19 M
|
$387.41 M
|
$354.29 M
|
$317.06 M
|
| Selling, General & Administrative Expenses |
$1.05 B
|
$1.03 B
|
$901.89 M
|
$850.75 M
|
$796.40 M
|
$735.27 M
|
$679.51 M
|
$632.34 M
|
$575.17 M
|
$524.08 M
|
| Other Expenses |
$0.00
|
$0.00
|
$0.00
|
$2.20 M
|
$1.46 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Operating Expenses |
$1.30 B
|
$1.25 B
|
$1.09 B
|
$1.11 B
|
$957.40 M
|
$876.52 M
|
$812.70 M
|
$750.21 M
|
$684.35 M
|
$625.20 M
|
| Cost And Expenses |
$2.94 B
|
$2.77 B
|
$2.56 B
|
$2.47 B
|
$2.28 B
|
$2.01 B
|
$1.85 B
|
$1.72 B
|
$1.56 B
|
$1.43 B
|
| Interest Income |
$2.42 M
|
$12.70 M
|
$5.63 M
|
$1.07 M
|
$434.00 K
|
$586.00 K
|
$427.00 K
|
$1.15 M
|
$5.25 M
|
$3.66 M
|
| Interest Expense |
$38.27 M
|
$31.21 M
|
$41.58 M
|
$39.86 M
|
$29.81 M
|
$33.13 M
|
$31.06 M
|
$34.74 M
|
$37.23 M
|
$32.05 M
|
| Depreciation & Amortization |
$106.46 M
|
$129.94 M
|
$114.91 M
|
$111.90 M
|
$104.60 M
|
$96.00 M
|
$88.01 M
|
$83.18 M
|
$83.14 M
|
$78.22 M
|
| EBITDA |
$1.47 B |
$1.28 B |
$1.22 B |
$1.01 B |
$1.04 B |
$793.81 M |
$643.68 M |
$575.66 M |
$501.42 M |
$431.69 M |
| EBITDA Ratio |
0.34
|
0.33
|
0.33
|
0.3
|
0.32
|
0.29
|
0.27
|
0.26
|
0.25
|
0.24
|
| Operating Income Ratio |
0.32
|
0.29
|
0.3
|
0.27
|
0.29
|
0.26
|
0.23
|
0.22
|
0.21
|
0.2
|
| Total Other Income/Expenses Net |
-$35.84 M
|
-$18.51 M
|
-$35.95 M
|
-$38.79 M
|
-$29.37 M
|
-$32.54 M
|
-$30.63 M
|
-$33.59 M
|
-$31.97 M
|
-$28.39 M
|
| Income Before Tax |
$1.32 B
|
$1.11 B
|
$1.06 B
|
$859.97 M
|
$902.65 M
|
$661.99 M
|
$522.22 M
|
$457.74 M
|
$381.06 M
|
$321.85 M
|
| Income Before Tax Ratio |
0.31
|
0.28
|
0.29
|
0.26
|
0.28
|
0.24
|
0.22
|
0.21
|
0.19
|
0.18
|
| Income Tax Expense |
$264.73 M
|
$221.96 M
|
$216.13 M
|
$180.88 M
|
$157.81 M
|
$79.85 M
|
$94.43 M
|
$80.70 M
|
$117.79 M
|
$99.79 M
|
| Net Income |
$1.06 B
|
$887.87 M
|
$845.04 M
|
$679.09 M
|
$744.85 M
|
$581.78 M
|
$427.72 M
|
$377.03 M
|
$263.14 M
|
$222.05 M
|
| Net Income Ratio |
0.25
|
0.23
|
0.23
|
0.2
|
0.23
|
0.21
|
0.18
|
0.17
|
0.13
|
0.13
|
| EPS |
13.17 |
10.77 |
10.17 |
8.12 |
8.74 |
6.82 |
4.97 |
4.34 |
3 |
2.47 |
| EPS Diluted |
13.08 |
10.67 |
10.06 |
8.03 |
8.6 |
6.71 |
4.89 |
4.26 |
2.94 |
2.44 |
| Weighted Average Shares Out |
$80.10 M
|
$82.47 M
|
$83.07 M
|
$83.62 M
|
$85.20 M
|
$85.34 M
|
$86.12 M
|
$86.86 M
|
$87.77 M
|
$89.73 M
|
| Weighted Average Shares Out Diluted |
$80.68 M
|
$83.25 M
|
$83.98 M
|
$84.60 M
|
$86.57 M
|
$86.72 M
|
$87.54 M
|
$88.47 M
|
$89.57 M
|
$90.88 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
